Fairman Group’s Chemed CHE Stock Holding History

Fairman Group’s Portfolio CHE Stock Details CHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-5	Closed	-$1.89K	–	335
2026 Q1	$1.89K	Hold	5	–	–	﹤0.01%	283
2025 Q4	$2.14K	Buy	+5	New	+$2.18K	﹤0.01%	284

Other funds holding CHE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

RRAM

River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

VBA

Van Berkom & Associates Montreal, Quebec, Canada $3.1B AUM 12.88% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return

SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Fairman Group's CHE Position: Q2 2026 in Review

Fairman Group sold out of Chemed (CHE) in Q2 2026, closing a stake of 5 shares — an estimated $1.89K sold.

Fairman Group first reported a position in CHE in Q4 2025 and held it in 2 quarters. The position peaked at $2.14K in Q4 2025. 236 funds tracked by Wall St. Rank hold CHE as of Q2 2026.

Fairman Group reported no remaining Chemed position as of Q2 2026 after selling out during the quarter.
Fairman Group sold 5 Chemed shares in Q2 2026, an estimated $1.89K.
Fairman Group first reported a position in Chemed in Q4 2025 and held it in 2 quarters.
Fairman Group's Chemed position peaked at $2.14K in Q4 2025.
236 funds tracked by Wall St. Rank held Chemed as of Q2 2026.

Based on Fairman Group's 13F filing for Q2 2026, filed 4 Aug 2026.